Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD.

Saved in:
Bibliographic Details
Title: Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD.
Authors: Stevanovic M; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Koulisis N; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Retina Los Angeles, Los Angeles, CA, USA., Chen T; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Moysidis SN; Retina Los Angeles, Los Angeles, CA, USA., Burkemper B; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Toy BC; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Rao NA; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Eliott D; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Humayun MS; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; USC Ginsburg Institute for Biomedical Therapeutics, Los Angeles, CA, USA.
Source: Journal of vitreoretinal diseases [J Vitreoretin Dis] 2025 Apr 21; Vol. 9 (4), pp. 406-415. Date of Electronic Publication: 2025 Apr 21 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 101700301 Publication Model: eCollection Cited Medium: Internet ISSN: 2474-1272 (Electronic) Linking ISSN: 24741264 NLM ISO Abbreviation: J Vitreoretin Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2474-1272
DOI:10.1177/24741264251332515